Fc receptor-like 3 gene polymorphisms confer susceptibility to rheumatoid arthritis in a Chinese population

Human Immunology

Volumn 71, Issue 12, 2010, Pages 1203-1208

  Wu, Hua ^a,b   Yang, Li Hua ^b   Zuo, Ji ^a   Liang, Ya Ling ^b   Li, Pei Qiang ^b   Liu, Wen ^a   Xie, Xiao Dong ^b  

^a FUDAN UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

FCRL3; Genetic association; Rheumatoid arthritis; Single nucleotide polymorphisms

Indexed keywords

CD16 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK;

ADULT; ALLELES; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

EID: 78149410629     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.08.002     Document Type: Article

References (48)

1. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 358:903-911.
2. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
3. Seldin M.F., Amos C.I., Ward R., Gregersen P.K. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999, 42:1071-1079.
4. Macgregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., Aho K., Silman A.J. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000, 43:30-37.
5. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987, 30:1205-1213.
6. Newton J.L., Harney S.M., Wordsworth B.P., Brown M.A. A review of the MHC genetics of rheumatoid arthritis. Genes Immun 2004, 5:151-157.
7. Deighton C.M., Walker D.J., Griffiths I.D., Roberts D.F. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989, 36:178-182.
8. Kochi Y., Yamada R., Kobayashi K., Takahashi A., Suzuki A., Sekine A., et al. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum 2004, 50:63-71.
9. Plenge R.M., Seielstad M., Padyukov L., Lee A.T., Remmers E.F., Ding B., et al. TRAF1-C5 as a risk locus for rheumatoid arthritisda genomewide study. N Engl J Med 2007, 357:1199-1209.
10. Plenge R.M., Cotsapas C., Davies L., Price A.L., de Bakker P.I., Maller J., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007, 39:1477-1482.
11. Gregersen P.K., Amos C.I., Lee A.T.Yue Lu, Remmers E.F., Kastner D.L., et al. REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009, 41:820-823.
12. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
13. Shimane K., Kochi Y., Horita T., Ikari K., Amano H., Hirakata M., et al. The association of a nonsynonymous singlenucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum 2010, 62:574-579.
14. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense singlenucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330-337.
15. Zhang Z.H., Chen F., Zhang X.L., Jin Y., Bai J., Fu S.B. PTPN22 allele polymorphisms in 15 Chinese populations. Int J Immunogenet 2008, 35:433-437.
16. Davis R.S., Wang Y.H., Kubagawa H., Cooper M.D. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA 2001, 98:9772-9777.
17. Kochi Y., Yamada R., Suzuki A., Harley J.B., Shirasawa S., Sawada T., et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005, 37:478-485.
18. Choi C.B., Kang C.P., Seong S.S., Bae S.C., Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case control study of Koreans. Arthritis Rheum 2006, 54:3838-3841.
19. Ikari K., Momohara S., Nakamura T., Hara M., Yamanaka H., Tomatsu T., Kamatani N. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 2006, 65:671-673.
20. Martinez A., Sanchez E., Valdivia A., Orozco G., Lopez-Nevot M.A., Pascual-Salcedo D., et al. Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 2006, 65:1188-1191.
21. Newman W.G., Zhang Q., Liu X., Walker E., Ternan H., Owen J., et al. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 2006, 54:3820-3827.
22. Thabet M.M., Wesoly J., Slagboom P.E., Toes R.E., Huizinga T.W. Three promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007, 66:803-806.
23. Owen C.J., Kelly H., Eden J.A., Merriman M.E., Pearce S.H., Merriman T.R. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007, 92:1106-1111.
24. Arnett F.C., Edworthy S.M., Bloch D.A., Mcshane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
25. Gross E., Arnold N., Goette J., Schwarz-Boeger U., Kiechle M. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 1999, 105:72-78.
26. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
27. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284.
28. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33:177-182.
29. Ke Li, Min Zhao, Shengping Hou, Liping Du, Kijlstra A., Peizeng Yang Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet's disease in a Chinese population with ophthalmic manifestations. Mol Vis 2008, 14:2136-2142.
30. Yi You, Wang Z., Deng G., Fei Hao Lack of association between Fc receptor-like 3 gene polymorphisms and systemic lupus erythematosus in Chinese population. J Dermatol Sci 2008, 52:118-122.
31. Chen J., Zheng H., Bei J.X., Sun L., Jia W.H., Li T., et al. Genetic structure of the Han Chinese population revealed by genome-wide SNP variation. Am J Hum Genet 2009, 85:775-785.
32. Julia A., Ballina J., Canete J.D., Balsa A., Tornero-Molina J., Naranjo A., et al. Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. Arthritis Rheum 2008, 58:2275-2286.
33. Ikari K., Kuwahara M., Nakamura T., Momohara S., Hara M., Yamanaka H., et al. Association between PADI4 and rheumatoid arthritis: A replication study. Arthritis Rheum 2005, 52:3054-3057.
34. Kang C.P., Lee H.S., Ju H., Cho H., Kang C., Bae S.C. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 2006, 54:90-96.
35. Barton A., Bowes J., Eyre S., Spreckley K., Hinks A., John S., Worthington J. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum 2004, 50:1117-1121.
36. Harney S.M., Meisel C., Sims A.M., Woon P.Y., Wordsworth B.P., Brown M.A. Genetic and genomic studies of PADI4 in rheumatoid arthritis. Rheumatol Oxf 2005, 44:869-872.
37. Caponi L., Petit-Teixeira E., Sebbag M., Bongiorni F., Moscato S., Pratesi F., et al. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis 2005, 64:587-593.
38. Martinez A., Valdivia A., Pascual-Salcedo D., Lamas J.R., Fernandez-Arquero M., Balsa A., et al. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatol Oxf 2005, 44:1263-1266.
39. Gabriel S.E., Crowson C.S., O'fallon M. Clinic M. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-85. Arthritis Rheum 2001, 42:415-420.
40. Begovich A.B., Chang M., Schrodi S.J. Meta-analysis evidence of a differential risk of the FCRL3 -169T/C polymorphism in white and east Asian rheumatoid arthritis patients. Arthritis Rheum 2007, 56:3168-3171.
41. Lee Y.H., Woo J.H., Choi S.J., Ji J.D., Song G.G. Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: A meta-analysis. Rheumatol Int 2010, 30:947-953.
42. Shimada M., Onizuka M., Machida S., Suzuki R., Kojima M., Miyamura K., et al. Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease. Br J Haematol 2007, 139:458-463.
43. Umemura T., Ota M., Hamano H., Katsuyama Y., Kiyosawa K., Kawa S. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 2006, 55:1367-1368.
44. Matesanz F., Fernandez O., Milne R.L., Fedetz M., Leyva L., Guerrero M., et al. The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis. J Neuroimmunol 2008, 195:146-150.
45. Martinez A., Mas A., de Las Heras V., Bartolome M., Arroyo R., Fernandez-Arquero M., et al. FcRL3 and multiple sclerosis pathogenesis: Role in autoimmunity?. J Neuroimmunol 2007, 189:132-136.
46. Umemura T., Ota M., Yoshizawa K., Katsuyama Y., Ichijo T., Tanaka E., et al. Lack of association between FCRL3 and FcgammaRII polymorphisms in Japanese type 1 autoimmune hepatitis. Clin Immunol 2007, 122:338-342.
47. Turunen J.A., Wessman M., Kilpikari R., Parkkonen M., Forsblom C., Groop P.H. The functional variant -169C/T in the FCRL3 gene does not increase susceptibility to type 1 diabetes. Diabet Med 2006, 23:925-927.
48. Simmonds M.J., Heward J.M., Carr-Smith J., Foxall H., Franklyn J.A., Gough S.C. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3- K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab 2006, 91:1056-1061.